Get started
Kilitch Drugs (India) LimitedKilitch Drugs (India) LimitedKilitch Drugs (India) Limited

Kilitch Drugs (India) Limited

No trades
See on Supercharts
OverviewFinancialsIdeasMindsTechnicalsForecastsSeasonals

Chart


Full chart

Key stats


Market capitalization
‪6.00 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20.40
Basic EPS (TTM)
16.75 INR
Net income (FY)
‪267.01 M‬ INR
Revenue (FY)
‪1.98 B‬ INR
Shares float
‪6.10 M‬
Beta (1Y)
1.31

Employees


Employees (FY)
187
Change (1Y)
+51 +37.50%
Revenue / Employee (1Y)
‪10.61 M‬ INR
Net income / Employee (1Y)
‪1.43 M‬ INR

About Kilitch Drugs (India) Limited


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Mukund Prataprai Mehta
Website
kilitch.com
Headquarters
Mumbai
Founded
1978
ISIN
INE729D01010
FIGI
BBG000D4WJD5
Kilitch Drugs (India) Ltd. engages in the developing, manufacturing, and marketing of pharmaceuticals, medicinal chemical, and botanical products. Its products include OSD, parenteral, nasal, opthalmic, nutritional, medical devices, and cosmetics products. The company was founded by Pratap Keshavji Mehta in 1978 and is headquartered in Mumbai, India.

Check out other big names from the same industry as KILITCH.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of KILITCH is 336.60 INR — it has decreased by −1.51% in the past 24 hours. Watch Kilitch Drugs (India) Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Kilitch Drugs (India) Limited stocks are traded under the ticker KILITCH.
KILITCH stock has fallen by −5.93% compared to the previous week, the month change is a −10.66% fall, over the last year Kilitch Drugs (India) Limited has showed a −2.02% decrease.
We've gathered analysts' opinions on Kilitch Drugs (India) Limited future price: according to them, KILITCH price has a max estimate of 464.00 INR and a min estimate of 464.00 INR. Watch KILITCH chart and read a more detailed Kilitch Drugs (India) Limited stock forecast: see what analysts think of Kilitch Drugs (India) Limited and suggest that you do with its stocks.
KILITCH reached its all-time high on Jul 15, 2025 with the price of 500.00 INR, and its all-time low was 16.65 INR and was reached on Jun 13, 2013. View more price dynamics on KILITCH chart.
See other stocks reaching their highest and lowest prices.
KILITCH stock is 2.42% volatile and has beta coefficient of 1.31. Track Kilitch Drugs (India) Limited stock price on the chart and check out the list of the most volatile stocks — is Kilitch Drugs (India) Limited there?
Today Kilitch Drugs (India) Limited has the market capitalization of ‪6.00 B‬, it has decreased by −5.24% over the last week.
Yes, you can track Kilitch Drugs (India) Limited financials in yearly and quarterly reports right on TradingView.
KILITCH net income for the last quarter is ‪81.90 M‬ INR, while the quarter before that showed ‪30.26 M‬ INR of net income which accounts for 170.67% change. Track more Kilitch Drugs (India) Limited financial stats to get the full picture.
Kilitch Drugs (India) Limited dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 5, 2025, the company has 187 employees. See our rating of the largest employees — is Kilitch Drugs (India) Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kilitch Drugs (India) Limited EBITDA is ‪316.36 M‬ INR, and current EBITDA margin is 16.20%. See more stats in Kilitch Drugs (India) Limited financial statements.
Like other stocks, KILITCH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kilitch Drugs (India) Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kilitch Drugs (India) Limited technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kilitch Drugs (India) Limited stock shows the neutral signal. See more of Kilitch Drugs (India) Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.